Summit Study - Home

Not satisfied with your current migraine treatment?

If you suffer from migraines, you may qualify for a clinical research study exploring this condition. The SUMMIT Study is evaluating a new investigational medicine for the acute treatment of migraines.

Migraines don’t have to keep you from reaching new heights. Consider joining the SUMMIT Study today.

You may be able to participate in the SUMMIT Study if YOU:

The investigational medicine is taken as a powder that is administered into your nose.

You will receive all study-related care at no cost, and participants may be compensated. Health insurance is not needed.

About Migraine

Migraine is a common, but incapacitating, neurological disease that affects approximately 39 million people in the United States alone.

Migraine is the

3rd

most prevalent illness in the world.

Migraine typically involves a severe throbbing recurring pain, usually on one side of the head.

Migraine is most common between the ages of 25 and 55.

About

0 %

of migraine sufferers have a family history of migraine.

Attacks are often accompanied by one or more of the following: nausea; vomiting; extreme sensitivity to sound, light, touch, and smell; and tingling or numbness of the extremities of the face.

Attacks usually last between 4 and 72 hours.

Clinical research can help to find safe and effective migraine treatments for everyone. This is where the SUMMIT Study comes in.

The SUMMIT Study is evaluating a new investigational medicine for the acute treatment of migraines.

Your choice regarding cookies on this site

We use cookies to optimize site functionality and give you the best experience.  Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.

For more detailed information on the cookies we use, please check our Privacy Policy.

By continuing to access this website you are giving us consent to collect cookies.